Stock Track | Repligen Soars 5.74% Intraday on Strong Q1 Results, Beats Estimates and Raises Guidance

Stock Track

May 05

Repligen Corporation's stock surged 5.74% during intraday trading on Tuesday, following the release of its first quarter 2026 financial results.

The bioprocessing technology company reported Q1 revenue of $194 million, a 15% year-over-year increase that slightly exceeded analyst expectations. More notably, adjusted earnings per share rose 23% to $0.48, significantly beating the consensus estimate of $0.39. The strong performance was driven by 11% organic revenue growth and 160 basis points of adjusted operating margin expansion.

Management reinforced investor confidence by reiterating full-year organic revenue growth guidance of 9%-13% while raising adjusted EPS guidance to $1.97-$2.05. The company also highlighted strategic progress including the divestiture of its non-core Polymem filtration business and a new OEM partnership in China designed to increase competitiveness and access to local manufacturing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1101302266"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1101302266\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1101302266?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-05 21:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1101302266","market":"nz","top_or_hot":-1,"title":"Stock Track | Repligen Soars 5.74% Intraday on Strong Q1 Results, Beats Estimates and Raises Guidance","media":"Stock Track","content":"<p>Repligen Corporation's stock surged 5.74% during intraday trading on Tuesday, following the release of its first quarter 2026 financial results.</p><p>The bioprocessing technology company reported Q1 revenue of $194 million, a 15% year-over-year increase that slightly exceeded analyst expectations. More notably, adjusted earnings per share rose 23% to $0.48, significantly beating the consensus estimate of $0.39. The strong performance was driven by 11% organic revenue growth and 160 basis points of adjusted operating margin expansion.</p><p>Management reinforced investor confidence by reiterating full-year organic revenue growth guidance of 9%-13% while raising adjusted EPS guidance to $1.97-$2.05. The company also highlighted strategic progress including the divestiture of its non-core Polymem filtration business and a new OEM partnership in China designed to increase competitiveness and access to local manufacturing.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Repligen Soars 5.74% Intraday on Strong Q1 Results, Beats Estimates and Raises Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Repligen Soars 5.74% Intraday on Strong Q1 Results, Beats Estimates and Raises Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-05 21:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Repligen Corporation's stock surged 5.74% during intraday trading on Tuesday, following the release of its first quarter 2026 financial results.</p><p>The bioprocessing technology company reported Q1 revenue of $194 million, a 15% year-over-year increase that slightly exceeded analyst expectations. More notably, adjusted earnings per share rose 23% to $0.48, significantly beating the consensus estimate of $0.39. The strong performance was driven by 11% organic revenue growth and 160 basis points of adjusted operating margin expansion.</p><p>Management reinforced investor confidence by reiterating full-year organic revenue growth guidance of 9%-13% while raising adjusted EPS guidance to $1.97-$2.05. The company also highlighted strategic progress including the divestiture of its non-core Polymem filtration business and a new OEM partnership in China designed to increase competitiveness and access to local manufacturing.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RGEN","symbol_name":"Repligen Corporation","start_time":0,"source_url":"","article_id":"1101302266","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1101302266","pubTimestamp":1777988257,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Repligen Corporation's stock surged 5.74% during intraday trading on Tuesday, following the release of its first quarter 2026 financial results.The bioprocessing technology company reported Q1...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RGEN":"Repligen Corporation"},"translate_title":"个股追踪|Repligen盘中大涨5.74%Q1业绩强劲超预期上调指引","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RGEN":1},"content_text":"Repligen Corporation's stock surged 5.74% during intraday trading on Tuesday, following the release of its first quarter 2026 financial results.The bioprocessing technology company reported Q1 revenue of $194 million, a 15% year-over-year increase that slightly exceeded analyst expectations. More notably, adjusted earnings per share rose 23% to $0.48, significantly beating the consensus estimate of $0.39. The strong performance was driven by 11% organic revenue growth and 160 basis points of adjusted operating margin expansion.Management reinforced investor confidence by reiterating full-year organic revenue growth guidance of 9%-13% while raising adjusted EPS guidance to $1.97-$2.05. The company also highlighted strategic progress including the divestiture of its non-core Polymem filtration business and a new OEM partnership in China designed to increase competitiveness and access to local manufacturing.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}